euro adhoc: Marseille-Kliniken AG
other
- Further real estate deal signed -
Sale of six care facilities for EUR 33.5 m
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
30.06.2008
Adhoc Release in accordance with section 15 of the German Securities Trading Act (WpHG)
Berlin, 30 June 2008. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has signed a sale-and-lease-back deal with a consortium of real estate investors, IMMAC Holding AG, Hamburg, as well as RP&C International / Public Service Properties Investments Ltd., London. Marseille-Kliniken AG has agreed a long-term lease for six care properties with a total of 567 beds with the investor consortium.
In total, the transaction has a volume of EUR 33.5 m and offers the company further financial scope to pursue its growth strategy in its core care business.
About 20% of Marseille-Kliniken AG´s portfolio consists of facilities it uses itself and about 80% which it has leased to other providers. The transaction will further reduce the company´s long-term financial debt.
The outlook for the financial year 2007/2008 dated 8 May 2008 is being confirmed. The company expects an annual turnover of EUR 233.5 m, an EBIT of EUR 24.0 m and a profit after tax of EUR 18.0 m.
End of adhoc release
end of announcement euro adhoc
Further inquiry note:
Marseille-Kliniken AG
Axel Hölzer
CEO
Alte Jakobstraße 79/80
10709 Berlin
GERMANY
Tel.: +4930 / 246 32-400
Fax: +4930 / 246 32-401
www.marseille-kliniken.com
or
Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
GERMANY
Tel.: +4940 / 320 279 10
Fax: +4940 / 320 279 114
www.hillermann-consulting.de
Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hamburg / regulated dealing